...

首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >COST-EFFFECTIVENES OF SONIDEGIB VERSUS VISMODEGIB FOR THE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED BASAL CELL CARCINOMA NOT AMENABLE TO SURGERY OR RADIOTHERAPY

【24h】

COST-EFFFECTIVENES OF SONIDEGIB VERSUS VISMODEGIB FOR THE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED BASAL CELL CARCINOMA NOT AMENABLE TO SURGERY OR RADIOTHERAPY

机译：SONIDEGIB VS VISMODEGIB在不适合手术或放射治疗的局部晚期基底细胞癌患者中的成本效益

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research》 |2016年第7期|共1页
作者
Purser M.; Mladsi D.; Kaye J. A.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类预防医学、卫生学;
关键词

相似文献

外文文献
中文文献
专利

1. COST-EFFFECTIVENES OF SONIDEGIB VERSUS VISMODEGIB FOR THE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED BASAL CELL CARCINOMA NOT AMENABLE TO SURGERY OR RADIOTHERAPY [J] . Purser M., Mladsi D., Kaye J. A. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：SONIDEGIB VS VISMODEGIB在不适合手术或放射治疗的局部晚期基底细胞癌患者中的成本效益
2. An Investigator-Initiated Open-Label Trial of Sonidegib in Advanced Basal Cell Carcinoma Patients Resistant to Vismodegib [J] . Danial Christina, Sarin Kavita Y., Oro Anthony E., Clinical cancer research: an official journal of the American Association for Cancer Research . 2016,第6期

机译：Sonidegib在抗Vismodegib的晚期基底细胞癌患者中进行的研究者发起的开放标签试验
3. Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial [J] . Migden Michael R., Guminski Alexander, Gutzmer Ralf, The lancet oncology . 2015,第6期

机译：局部晚期或转移性基底细胞癌（BOLT）患者用两种不同剂量的Sonidegib治疗：一项多中心，随机，双盲2期试验
4. IL-12 is a Useful Marker to Predict Clinical Outcome in Radiotherapy: Down-Regulation of IL-12 Increases Treatment Failure in Locally Advanced Hepatocellular Carcinoma [C] . En-Jung Lee, Yan-Gun Suh, Seojin Lee, International Molecular Medicine Tri-Conference. . 2015

机译：IL-12是一种有用的标记，可预测放疗中的临床结果：IL-12的下调增加了局部晚期肝细胞癌的治疗失败
5. Diffusion-weighted magnetic resonance imaging in monitoring treatment response in patients with locally advanced breast cancer. [D] . Singer, Lisa. 2010

机译：扩散加权磁共振成像可监测局部晚期乳腺癌患者的治疗反应。
6. Vismodegib in neoadjuvant treatment of locally advanced basal cell carcinoma: First results of a multicenter open-label phase 2 trial (VISMONEO study): Neoadjuvant Vismodegib in Locally Advanced Basal Cell Carcinoma [O] . Nicolas Bertrand, Pierre Guerreschi, Nicole Basset-Seguin, 2021

机译：Vismodegib在Neoadjuvant治疗当地先进的基础细胞癌：多中心开放标签第2阶段试验（Vismoneo研究）：Neoadjuvant Vismodegib在当地先进的基础细胞癌
7. Compassionate use of vismodegib and adjuvant radiotherapy in the treatment of multiple locally advanced and inoperable basal cell carcinomas and squamous cell carcinomas of the skin [O] . Gathings Robert M., Orscheln Courtney S., Huang William W. 2014

机译：vismodegib和辅助放疗的同情使用可治疗多种局部晚期和不可手术的皮肤基底细胞癌和鳞状细胞癌

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号